Overview Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers Status: RECRUITING Trial end date: 2025-12-01 Target enrollment: Participant gender: Summary A Phase 1, Open-Label Study to Assess Pharmacokinetics, Safety and Tolerability of G1090N in Healthy SubjectsPhase: PHASE1 Details Lead Sponsor: Genfit